Keyword search (3,448 papers available)


Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.

Author(s): Conklin J, Farrell B, Suleman S

Res Social Adm Pharm. 2019 06;15(6):796-800 Authors: Conklin J, Farrell B, Suleman S

Article GUID: 30241874
Deprescribing guidelines: An international symposium on development, implementation, research and health professional education.

Author(s): Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W

Res Social Adm Pharm. 2019 06;15(6):780-789 Authors: Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W

Article GUID: 30241875
Deprescribing: Future directions for research.

Author(s): Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B

Res Social Adm Pharm. 2019 06;15(6):801-805 Authors: Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B

Article GUID: 30241876
Title:Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.
Authors:Conklin J,  Farrell B,  Suleman S
Link:https://www.ncbi.nlm.nih.gov/pubmed/30241874?dopt=Abstract
DOI:10.1016/j.sapharm.2018.08.012
Category:Res Social Adm Pharm
PMID:30241874
Dept Affiliation: CONCORDIA
1 Bruyère Research Institute, 43 Bruyère St., K1N 5C8, Ottawa, Ontario, Canada; Concordia University, Montreal, Quebec, Canada. Electronic address: james.conklin@concordia.ca.
2 Bruyère Research Institute, 43 Bruyère St., K1N 5C8, Ottawa, Ontario, Canada; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada; School of Pharmacy, University of Waterloo, Waterloo, Canada. Electronic address: bfarrell@bruyere.org.
3 Bruyère Research Institute, 43 Bruyère St., K1N 5C8, Ottawa, Ontario, Canada. Electronic address: suleman@ualberta.ca.

Description:

Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.

Res Social Adm Pharm. 2019 06;15(6):796-800

Authors: Conklin J, Farrell B, Suleman S

Abstract

A Bruyère Evidence-Based Deprescribing Guideline Symposium was held in March 2018; one component focused on implementing deprescribing guidelines into practice. An interactive discussion activity allowed the 107 participants to share experiences and ideas concerning the barriers and facilitators that arise when moving deprescribing guidelines into frontline practice. Participants identified 8 broad challenges and problem areas. These included challenges and barriers that arise in the daily practices of pharmacists and prescribers and in other health care settings, and those related to existing policies, processes, and financial structures. They also identified 10 factors that facilitated implementation efforts, including: educating patients, caregivers, health care providers (HCPs) and staff; improving collaboration across practice disciplines; expanding the evidence for deprescribing; and fostering organizational cultures of deprescribing. The results indicate that participants are committed to deprescribing and are moving forward with efforts to bring about change. Participants recognize that the implementation of deprescribing is best conceived of as a comprehensive systems change, and that patients and the public need to be involved in deprescribing processes and activities.

PMID: 30241874 [PubMed - indexed for MEDLINE]